Results 121 to 130 of about 26,161 (209)

Chimeric Anti-Glypican 1 Antibodies Exert Antitumor Activities in Xenograft Models of Lung and Pancreatic Cancers. [PDF]

Int J Mol Sci
Yamamoto H, Suzuki H, Ohishi T, Satofuka H, Kaneko MK, Kato Y.   +5 more
europepmc   +1 more source

ADCC (No.68～72)

Japanese Journal of Clinical Immunology, 1978
openaire   +2 more sources

Cytokine preactivation and ADCC: a potent strategy for enhancing human NK cell effector functions against 3D tumor models. [PDF]

Front Immunol
Lopez-Pardo A, Amarilla-Irusta A, Iturbe-Larrondo A, Juan IS, Sandá V, Zenarruzabeitia O, Ciccarelli FD, Borrego F, Amo L.   +8 more
europepmc   +1 more source

HSV-2 gE2/gI2 are immune evasion molecules that bind IgG Fc to inhibit antibody-dependent cellular cytotoxicity. [PDF]

Front Immunol
Tebaldi G, Egan KP, Hook LM, Cairns TM, Bergstrom T, Campbell KS, Cohen GH, Friedman HM.   +7 more
europepmc   +1 more source

Specific depletion of TIGIT^high CD226^- clonally expanded intratumoral Tregs defines safe and effective TIGIT targeting. [PDF]

J Immunother Cancer
Zhou H, Li J, Mei S, Zhang M, Zhao H, Yan K, Cheng Y, Zhou Q, Zheng P, Liu Y, Zhang P, Li H, Lu W, Zhang Y.   +13 more
europepmc   +1 more source

Interferon stimulation and NKG2D expression drive enhanced natural killer cell antibody-dependent cellular cytotoxicity against viral infections. [PDF]

J Leukoc Biol
Chan L, Pinedo K, Yang S, Blomkalns AL, Nadeau KC, Rogers AJ, Blish CA.   +6 more
europepmc   +1 more source

FcγR-driven chimeric receptor T cells in cancer therapy: a novel frontier in antibody-guided immunotherapy. [PDF]

Cancer Cell Int
Marei HE, Pozzoli G, Caratelli S, Cenciarelli C.   +3 more
europepmc   +1 more source

Recent developments in salivary gland pathology after the WHO 2024 classification: new developments in existing entities and evolving new entities. [PDF]

Virchows Arch
Skálová A, Laco J, Thompson LDR, Bradová M, Vander Poorten V, Araújo ALD, Stenman G, Leivo I, Agaimy A, Ferlito A.   +9 more
europepmc   +1 more source

Progress and prospects for herpesvirus vaccination using gB antigens. [PDF]

Front Immunol
English S, Khan-Qureshi A, Douglas AD.
europepmc   +1 more source

Insights into ectodomain shedding as a novel target in natural killer cell-based immunotherapy for cancer. [PDF]

Front Immunol
Pimenta R, Arai J, Ribeiro de Lima Brandao L, Schmidt P, da Silva Bortoleti BT, Ferrari de Andrade L.   +5 more
europepmc   +1 more source